Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phenylethanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105237346B reveals high-purity chiral alcohol synthesis via crystallization. Offers cost reduction and supply reliability for pharma intermediates.
Patent CN103214344B reveals efficient alkyne conversion. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115448813B details a manganese-catalyzed route for Crizotinib intermediates. Achieves 95% ee with reduced costs and scalable mild conditions for global supply chains.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN101891595A details a cost-effective chemical synthesis of hydroxytyrosol using 3,4-dihydroxybenzaldehyde, offering scalable production and high purity for pharmaceutical applications.
Advanced two-step precipitation method for phenylethanolamine compounds. Reduces cost and steps for pharmaceutical intermediates. Reliable supplier for global scale-up.
Novel biocatalytic route for Hydroxytyrosol using polyphenol oxidase and ascorbic acid inhibition ensures high purity and scalable production for pharmaceutical intermediates.
Patent CN102477000A details a streamlined 5-step synthesis for beta-2 agonists, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104726354A details a novel spore microcapsule enzyme method for (R)-phenylethanol. Achieves 99% ee and enhanced stability for reliable pharmaceutical intermediate supply chains.
Patent CN111777518A discloses a cost-effective 4-step route for deuterated Phenylethanolamine A, offering high purity for analytical standards and breaking import monopolies.
Patent CN102876734B details a novel carbonyl reductase for high-purity chiral alcohol production, offering significant cost and supply chain advantages for API intermediates.
Patent CN106699507B details water-based hydrogenation for high-purity alpha-phenylethanol. This green process ensures supply chain reliability and significant cost reduction.
Patent CN105087668A reveals high-yield biocatalytic route for chiral intermediates. Achieve cost reduction and supply reliability with green manufacturing processes.
Patent CN105087674A details high-yield biocatalytic synthesis. Offers supply chain stability and cost reduction in chiral intermediate manufacturing for global partners.
Patent CN105039433A reveals high-yield yeast catalysis. Offers supply chain stability and cost reduction in pharmaceutical intermediate manufacturing.
Explore the synthesis of novel phenylethanolamine compounds for asthma treatment. Discover cost-effective manufacturing routes and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN108164398A details a novel reduction method eliminating column chromatography. This breakthrough ensures scalable production and substantial cost reduction for global supply chains.
Solve hydroxytyrosol production challenges: 95%+ purity, 90% yield, no column chromatography. Reduce costs & scale up with optimized LiAlH4 process.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.